Cargando…

Antiviral Drug Discovery for the Treatment of COVID-19 Infections

The coronavirus disease 2019 (COVID-19) pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a recently emerged human coronavirus. COVID-19 vaccines have proven to be successful in protecting the vaccinated from infection, reducing the severity of disease, and dete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ng, Teresa I., Correia, Ivan, Seagal, Jane, DeGoey, David A., Schrimpf, Michael R., Hardee, David J., Noey, Elizabeth L., Kati, Warren M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143071/ https://www.ncbi.nlm.nih.gov/pubmed/35632703 http://dx.doi.org/10.3390/v14050961

Ejemplares similares

Recommender Systems in Antiviral Drug Discovery
por: Sosnina, Ekaterina A., et al.
Publicado: (2020)

Current Landscape of Antiviral Drug Discovery
por: Blair, Wade, et al.
Publicado: (2016)

Structural biology in antiviral drug discovery
por: Bassetto, Marcella, et al.
Publicado: (2016)

Successes in antiviral drug discovery: a tribute to Nick Meanwell
por: Rotella, David P.
Publicado: (2023)

Desymmetrization of pibrentasvir for efficient prodrug synthesis
por: Voight, Eric A., et al.
Publicado: (2021)

Virus–host interactomes — antiviral drug discovery
por: Ma-Lauer, Yue, et al.
Publicado: (2012)

Norovirus: Targets and tools in antiviral drug discovery
por: Rocha-Pereira, Joana, et al.
Publicado: (2014)

Functional genomics in virology and antiviral drug discovery
por: DeFilippis, Victor, et al.
Publicado: (2003)

A phenomics approach for antiviral drug discovery
por: Rietdijk, Jonne, et al.
Publicado: (2021)

Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery
por: Abdulaziz, Leena, et al.
Publicado: (2022)

Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors
por: Chang, Kyeong-Ok, et al.
Publicado: (2019)

Antiviral Drug Discovery To Address the COVID-19 Pandemic
por: Richman, Douglas D.
Publicado: (2020)

Editorial of Special Column on Antiviral Drug Discovery and Pharmacology
por: Wang, Jun, et al.
Publicado: (2022)

Current Strategies of Antiviral Drug Discovery for COVID-19
por: Mei, Miao, et al.
Publicado: (2021)

Imidazole derivatives: Impact and prospects in antiviral drug discovery
por: Teli, Pankaj, et al.
Publicado: (2022)

Promising Schiff bases in antiviral drug design and discovery
por: Kaushik, Shikha, et al.
Publicado: (2023)

Facilitating Antiviral Drug Discovery Using Genetic and Evolutionary Knowledge
por: Xu, Xuan, et al.
Publicado: (2021)

Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery
por: Li, Xinlei, et al.
Publicado: (2021)

Accelerating antiviral drug discovery: lessons from COVID-19
por: von Delft, Annette, et al.
Publicado: (2023)

Antiviral drugs
por: Koch, Oliver, et al.
Publicado: (2010)

Virus-host interactomics: new insights and opportunities for antiviral drug discovery
por: de Chassey, Benoît, et al.
Publicado: (2014)

The nucleocapsid protein of zoonotic betacoronaviruses is an attractive target for antiviral drug discovery
por: Lang, Yuekun, et al.
Publicado: (2021)

The Discovery and Development of a Potent Antiviral Drug, Entecavir, for the Treatment of Chronic Hepatitis B
por: Tang, Hong, et al.
Publicado: (2013)

Antiviral and Immunomodulatory Drugs
por: Sykes, Jane E., et al.
Publicado: (2014)

Antiviral Agents: Discovery to Resistance
por: Adamson, Catherine S.
Publicado: (2020)

Antiviral Drugs for Acute Infections
por: Powell, K.L., et al.
Publicado: (2017)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

Discovery and development of antiviral drugs for biodefense: Experience of a small biotechnology company
por: Bolken, Tove C., et al.
Publicado: (2008)

SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
por: Liu, Xiaonan, et al.
Publicado: (2021)

Editor Profiles: Guest Editors of Special Column on Antiviral Drug Discovery and Pharmacology
Publicado: (2022)

Small Molecule Antiviral Compound Collection (SMACC): a database to support the discovery of broad-spectrum antiviral drug molecules
por: Martin, Holli-Joi, et al.
Publicado: (2022)

Discovery of SARS-CoV-2 Antivirals through Large-scale Drug Repositioning
por: Riva, Laura, et al.
Publicado: (2020)

Discovery of Antivirals Using Phage Display
por: Sokullu, Esen, et al.
Publicado: (2021)

Direct-Acting Antiviral Agents for Hepatitis C Virus Infection—From Drug Discovery to Successful Implementation in Clinical Practice
por: Dietz, Christopher, et al.
Publicado: (2022)

Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses
por: Fernandes, Rafaela S., et al.
Publicado: (2020)

Editorial: Emerging and old viral diseases: Antiviral drug discovery from medicinal plants
por: Rahmatullah, Mohammed, et al.
Publicado: (2022)

Discovery of Potent Broad Spectrum Antivirals Derived from Marine Actinobacteria
por: Raveh, Avi, et al.
Publicado: (2013)

Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery
por: Zakharova, Maria Yu., et al.
Publicado: (2021)

Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library
por: Pascoalino, Bruno S., et al.
Publicado: (2016)

Viral Nucleases from Herpesviruses and Coronavirus in Recombination and Proofreading: Potential Targets for Antiviral Drug Discovery
por: Wright, Lee R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qmh76pu910ijjuvolrrvrid0f1